USP Analysis of Almotriptan Tablets and Related Substances

Significance of the Topic

Almotriptan is a selective 5-HT1B/1D receptor agonist widely used for migraine relief. USP monograph provides a standard analytical method for its quality control.

QC laboratories often lack UHPLC systems required for sub-2 µm columns, highlighting the need for HPLC-compatible methods that maintain resolution and robustness.

Objectives and Study Overview

This study adapts the USP monograph method for the analysis of almotriptan tablets and related impurities from UHPLC to HPLC.
The goal is to preserve chromatographic performance while reducing system backpressure to suit typical QC lab equipment.

Methodology

Tablet samples were pulverized, extracted with acetonitrile/phosphate buffer (10:90 v/v), sonicated, centrifuged, and filtered.
Standard solutions of almotriptan and related impurities were prepared according to the USP monograph specifications.
Chromatographic conditions included UV detection at 210 nm, column temperature at 40 °C, and injection volume of 3 µL.

Used Instrumentation

• Shimadzu Nexera X2 UHPLC system
• Shim-pack Velox C18 columns: 1.8 µm, 2.1×100 mm (UHPLC) and 2.7 µm, 3.0×150 mm (HPLC)
• UV–Vis detector set at 210 nm

Main Results and Discussion

The original 1.8 µm column generated a backpressure of 55.3 MPa, restricting analysis to UHPLC.
Switching to a 2.7 µm core–shell column lowered backpressure below 40 MPa (23.2 MPa at 0.55 mL/min and 31.5 MPa at 0.75 mL/min), enabling HPLC operation.
System suitability tests met USP criteria: resolution ≥ 1.5, tailing factor ≤ 3.0, retention-time and area RSD < 2.0%.
Theoretical plate numbers increased by over 150% on the HPLC column, while relative retention times remained consistent with USP values.

Benefits and Practical Applications

This HPLC method allows routine QC analysis of almotriptan without UHPLC equipment.
It offers robust performance, compliance with USP standards, and efficient impurity separation in pharmaceutical quality control.

Future Trends and Opportunities

Further optimization could target shorter analysis times and higher throughput.
Core–shell column technologies may be extended to other triptan compounds and related drug substances.
Integration with automated sample preparation could enhance QC laboratory efficiency.

Conclusion

The USP monograph method for almotriptan was successfully transferred from UHPLC to HPLC by using a Shim-pack Velox C18 core–shell column on the Nexera X2 system.
Chromatographic performance was maintained while achieving lower system backpressure suitable for standard HPLC instruments.

References

• Sandrini G, Perrotta A, Arce Leal NL, Buscone S, Nappi G. Neuropsychiatr Dis Treat. 2007;3(6):799–809.
• Bou J, Gras J, Cortijo J, Morcillo EJ, Llenas J, Palacios JM. Cephalalgia. 2001;21(8):804–812.
• Hoskin KL, Lambert GA, Donaldson C, Zagami AS. Brain Res. 2004;998(1):91–99.
• United States Pharmacopeia 41–NF 36. Almotriptan Tablets Monograph 2659. The United States Pharmacopeia Convention; 2017.